GSK blood cancer drug nearly halves risk of death in late-stage trial staradvertiser.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from staradvertiser.com Daily Mail and Mail on Sunday newspapers.
GSK's Quest to Bring Myeloma Drug Back to the Market Stops for a Data Drop at ASCO medcitynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medcitynews.com Daily Mail and Mail on Sunday newspapers.
Dostarlimab plus chemotherapy is the only immuno-oncology-based therapy that showed statistically significant and clinically meaningful survival benefit in the overall patient population.